Net Cash Provided by (Used in) Operating Activities |
-68.7K |
USD |
-19.5% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
88.5K |
USD |
+116% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
+400% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
49.8M |
shares |
+12.5% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.56K |
USD |
+73.9% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
536 |
USD |
+168% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.72M |
USD |
+313% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
1.72M |
USD |
+313% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
Depreciation |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
Operating Lease, Liability, Current |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
6.02K |
USD |
|
Q3 2023 |
Q3 2023 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
3.29K |
USD |
|
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.72M |
USD |
+313% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
2.28M |
USD |
+55.3% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
703 |
USD |
-33.6% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
0 |
USD |
-100% |
Q2 2025 |
Q2 2025 |
Interest Expense |
1.54K |
USD |
+81.8% |
Q1 2024 |
Q1 2024 |